BNC Share Price

Open 21.40 Change Price %
High 21.40 1 Day 0.00 0.00
Low 21.40 1 Week 0.31 1.47
Close 21.40 1 Month -0.89 -3.99
Volume 500 1 Year 21.19 10090.48
52 Week High 23.18
52 Week Low 20.15
BNC Important Levels
Resistance 2 21.40
Resistance 1 21.40
Pivot 21.40
Support 1 21.40
Support 2 21.40
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
BBD-B 2.25 3.21%
ECA 14.46 0.91%
ECA 14.46 0.91%
ECA 14.46 0.91%
More..
TSE Canada Top Gainers Stocks
TVI 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
BLU 0.40 21.21%
CUM 0.90 13.92%
CUM 0.90 13.92%
BU 1.66 12.93%
More..
TSE Canada Top Losers Stocks
TPL 0.02 -33.33%
TPL 0.02 -33.33%
GBV 0.46 -24.59%
CTU-A 0.19 -9.52%
RN 0.11 -8.33%
RN 0.11 -8.33%
KOR 0.80 -8.05%
KOR 0.80 -8.05%
RKN 0.82 -7.87%
RKN 0.82 -7.87%
More..

Bioniche Life Sciences Inc (TSE: BNC)

BNC Technical Analysis 5
As on 23rd May 2017 BNC Share Price closed @ 21.40 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.41 & Strong Buy for SHORT-TERM with Stoploss of 13.70 we also expect STOCK to react on Following IMPORTANT LEVELS.
BNC Target for May
1st Target up-side 22.34
2nd Target up-side 22.38
3rd Target up-side 22.42
1st Target down-side 22.24
2nd Target down-side 22.2
3rd Target down-side 22.16
BNC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioniche.com
BNC Address
BNC
231 Dundas Street East
Belleville, ON K8N 1E2
Canada
Phone: 613-966-8058
Fax: 613-966-4177
BNC Latest News
A conservative TFSA that can take on more risk   MoneySense   - 27th May 17
Horizons Announces May 2017 Distributions for its Covered Call ETFs   MarketWatch   - 24th May 17
How active is your fund manager?   MoneySense   - 24th Apr 17
Purpose Investments Inc. Announces April Distributions   Marketwired (press release)   - 20th Apr 17
Purpose Investments Inc. Announces March Distributions   Marketwired (press release)   - 23rd Mar 17
There's more to the RRSP than mutual funds and ETFs, but you have to tread ...   Financial Post   - 17th Feb 17
3 Bulletproof ETFs For Income In 2017   Forbes   - 01st Feb 17
How to earn tax-efficient dividend income   MoneySense   - 01st Feb 17
Purpose Investments Announces the Launch of Two Innovative Income Funds   Marketwired (press release)   - 26th Oct 16
Is my ETF's yield too good to be true?   The Globe and Mail   - 15th Oct 16
Interactive Technical Analysis Chart Bioniche Life Sciences Inc ( BNC TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Bioniche Life Sciences Inc
BNC Business Profile
Bioniche Life Sciences Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, manufacture, and marketing of proprietary products for the human health markets. Its lead product, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, is a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans, which is in Phase III clinical development. The company was formerly known as Vetrepharm Animal Health Inc. Bioniche Life Sciences Inc. was founded in 1979 and is headquartered in Belleville, Canada.